Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VERV Verve Therapeutics

休市中 08-23 16:00:00 EDT

4.94

+0.10

+2.07%

盘后4.99

+0.05+1.01%

19:51 EDT

最高5.02	最低4.81	成交量146.87万
今开4.89	昨收4.84	日振幅4.34%
总市值4.18亿	流通市值3.35亿	总股本8,462万
成交额719.37万	换手率2.17%	流通股本6,777万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VERV","market":"US","secType":"STK","nameCN":"Verve Therapeutics","latestPrice":4.94,"timestamp":1724443200000,"preClose":4.84,"halted":0,"volume":1468735,"hourTrading":{"tag":"盘后","latestPrice":4.99,"preClose":4.94,"latestTime":"19:51 EDT","volume":20633,"amount":101839.0097,"timestamp":1724457092623},"delay":0,"floatShares":67766705,"shares":84624529,"eps":-2.565962,"marketStatus":"休市中","marketStatusCode":7,"change":0.1,"latestTime":"08-23 16:00:00 EDT","open":4.89,"high":5.02,"low":4.81,"amount":7193664.722660501,"amplitude":0.043388,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.565962,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1623902400000,"adjPreClose":4.84,"preHourTrading":{"tag":"盘前","latestPrice":4.95,"preClose":4.84,"latestTime":"08:58 EDT","volume":177,"amount":870.05058,"timestamp":1724417917330},"postHourTrading":{"tag":"盘后","latestPrice":4.99,"preClose":4.94,"latestTime":"19:51 EDT","volume":20633,"amount":101839.0097,"timestamp":1724457092623},"volumeRatio":0.8070718611836242,"impliedVol":0.454,"impliedVolPercentile":0.0595},"requestUrl":"/m/hq/s/VERV/wiki","defaultTab":"wiki","newsList":[{"id":"2460824154","title":"Verve Therapeutics, Inc.2024财年第二财季实现净利润-49.81百万美元，同比增加7.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460824154","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460824154?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824038,"startTime":"0","endTime":"0","summary":"8月17日，Verve Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-49.81百万美元，同比增加7.73%；其中营业收入为6.69百万美元，同比增加220.10%，每股基本收益为-0.59美元。从资产负债表来看，Verve Therapeutics, Inc.总负债1.55亿美元，其中短期债务10.29百万美元，资产负债比为4.53，流动比率为0.15。机构评级：截至2024年8月17日，当前有9家机构对Verve Therapeutics, Inc.目标价做出预测，其中目标均价为25.11美元，其中最低目标价为15.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000614959f2d61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000614959f2d61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ"],"gpt_icon":0},{"id":"2459842793","title":"Verve Therapeutics, Inc.盘中异动 大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459842793","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459842793?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:30","pubTimestamp":1723728644,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时30分，Verve Therapeutics, Inc.股票出现异动，股价大幅拉升5.45%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2128.10%、1428.93%、329.34%，振幅较大的相关个股有Celcuity Inc.、Tyra Biosciences, Inc.、Vaxart, Inc. - Common Stock，振幅分别为9.31%、5.10%、5.07%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213044ab5dd814&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213044ab5dd814&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VERV","LENZ","BK4539"],"gpt_icon":0},{"id":"2459393681","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459393681","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459393681?lang=zh_cn&edition=full","pubTime":"2024-08-13 00:14","pubTimestamp":1723479254,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日00时14分，Verve Therapeutics, Inc.股票出现波动，股价急速下挫5.01%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.32%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081300141498e34d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081300141498e34d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","VERV","BK4139","LENZ"],"gpt_icon":0},{"id":"2458134445","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458134445","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458134445?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:37","pubTimestamp":1723135042,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时37分，Verve Therapeutics, Inc.股票出现异动，股价快速跳水5.11%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.82%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为405.56%、292.56%、185.98%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为126.67%、54.41%、45.58%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809003722af96a31b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809003722af96a31b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","VERV"],"gpt_icon":0},{"id":"2457577595","title":"Verve Therapeutics, Inc.盘中异动 快速下挫8.72%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457577595","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457577595?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864796,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分，Verve Therapeutics, Inc.股票出现异动，股价急速跳水8.72%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为983.82%、35.96%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为13.04%、12.19%、11.60%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213316957f2ec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213316957f2ec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2456459404","title":"Verve Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456459404","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456459404?lang=zh_cn&edition=full","pubTime":"2024-08-02 00:50","pubTimestamp":1722531045,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日00时50分，Verve Therapeutics, Inc.股票出现波动，股价急速跳水5.00%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Dermata Therapeutics Inc C/Wts 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为1830.01%、346.38%、211.64%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Virax Biolabs Group Limited、Biomea Fusion, Inc.，振幅分别为57.55%、43.37%、43.27%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802005045af9566c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802005045af9566c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2454534054","title":"Verve Therapeutics, Inc.盘中异动 股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454534054","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454534054?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:37","pubTimestamp":1722001024,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时37分，Verve Therapeutics, Inc.股票出现波动，股价大幅上涨5.61%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Cel-Sci Corporation涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3220.08%、102.11%、35.59%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Promis Neurosciences Inc.，振幅分别为45.29%、39.67%、20.82%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213705aefbb1d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726213705aefbb1d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2453819018","title":"Verve Therapeutics, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453819018","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453819018?lang=zh_cn&edition=full","pubTime":"2024-07-24 23:03","pubTimestamp":1721833428,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日23时03分，Verve Therapeutics, Inc.股票出现异动，股价大幅下跌5.01%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Dermata Therapeutics, Inc.、Pieris Pharmaceuticals, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Azitra Inc、Gri Bio, Inc.较为活跃，换手率分别为7603.19%、1195.53%、622.49%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Sangamo Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts ，振幅分别为191.54%、99.60%、72.46%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724230348941fa2ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724230348941fa2ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERV","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2453056890","title":"Verve Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453056890","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453056890?lang=zh_cn&edition=full","pubTime":"2024-07-23 22:34","pubTimestamp":1721745268,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日22时34分，Verve Therapeutics, Inc.股票出现异动，股价大幅上涨5.15%。Verve Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Azitra Inc、Adial Pharmaceuticals, Inc、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Azitra Inc、Adial Pharmaceuticals, Inc、Gri Bio, Inc.较为活跃，换手率分别为4076.12%、2854.85%、133.94%，振幅较大的相关个股有Azitra Inc、Adial Pharmaceuticals, Inc、Dermata Therapeutics, Inc.，振幅分别为365.43%、137.74%、51.54%。Verve Therapeutics, Inc.公司简介：Verve Therapeutics Inc是一家基因药物公司，开创了心血管疾病护理的新方法，将治疗从慢性管理转变为单疗程基因编辑药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723223429af93ac76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723223429af93ac76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","VERV","BK4539"],"gpt_icon":0},{"id":"2446893506","title":"Verve Therapeutics Inc - 将董事会扩大至九名成员。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446893506","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446893506?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:48","pubTimestamp":1719575313,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VERV","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2446284598","title":"千禧管理公司报告截至6月21日对Verve Therapeutics Inc持有5.1%的被动股份 - 根据SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2446284598","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446284598?lang=zh_cn&edition=full","pubTime":"2024-06-28 04:44","pubTimestamp":1719521074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","VERV","BK4539","LENZ"],"gpt_icon":0},{"id":"2440161947","title":"Verve Therapeutics根据纳斯达克上市规则5635 (C) (4) 宣布激励补助金","url":"https://stock-news.laohu8.com/highlight/detail?id=2440161947","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440161947?lang=zh_cn&edition=full","pubTime":"2024-06-01 04:01","pubTimestamp":1717185660,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NQmain","LU0052756011.USD","LENZ","LU1267930227.SGD","SQQQ","LU0130102774.USD","LU0310800965.SGD","LU0320765646.SGD","LU0648001328.SGD","QQQ","TQQQ","LU0980610538.SGD","LU0128525689.USD","03086","BK4139","BK1147","BK4504","BK4539","BK4566","NDX","IE00BSNM7G36.USD","LU0098860793.USD","LU1162221912.USD","ARTL","BK4007","159632","LU1201861249.SGD","BK4207","MNQmain",".IXIC","PSQ","QID","BK4588","QLD","BK4534","BK4585","VERV"],"gpt_icon":0},{"id":"2439964258","title":"Verve Therapeutics宣布领导层更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2439964258","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439964258?lang=zh_cn&edition=full","pubTime":"2024-05-31 19:00","pubTimestamp":1717153200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LENZ","BK4539","VERV"],"gpt_icon":0},{"id":"2437164476","title":"成分股Exscientia ADR收跌9.44%，Biomea Fusion、Dyne、Day One Biopharmaceuticals、Verve Therapeutics也跌8.","url":"https://stock-news.laohu8.com/highlight/detail?id=2437164476","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437164476?lang=zh_cn&edition=full","pubTime":"2024-05-22 05:30","pubTimestamp":1716327053,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","SAGE","BK4563","VERV","EXAI","BK4585","RAPT","RLAY","BMEA","BK4539","LENZ"],"gpt_icon":0},{"id":"2434041366","title":"HC Wainwright &amp; Co.：重申Verve Therapeutics(VERV.US)评级，由买入调整至买入评级, 目标价15.","url":"https://stock-news.laohu8.com/highlight/detail?id=2434041366","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434041366?lang=zh_cn&edition=full","pubTime":"2024-05-10 02:54","pubTimestamp":1715280893,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VERV","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2426477425","title":"成分股Tourmaline Bio收跌13.02%，Nurix跌10.24%，Adaptive Biotechnologies跌8.","url":"https://stock-news.laohu8.com/highlight/detail?id=2426477425","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426477425?lang=zh_cn&edition=full","pubTime":"2024-04-11 05:33","pubTimestamp":1712784810,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4585","BK4139","VERA","VERV","BK4588","JANX","TRML","LENZ","BK4539"],"gpt_icon":0},{"id":"2426343169","title":"美国研究综述-阿波罗、特斯拉、UDR","url":"https://stock-news.laohu8.com/highlight/detail?id=2426343169","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426343169?lang=zh_cn&edition=full","pubTime":"2024-04-10 14:51","pubTimestamp":1712731906,"startTime":"0","endTime":"0","summary":"    路透社4月10日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括阿波罗、特斯拉和 UDR。要闻             * 阿波罗  ：杰富瑞将目标价从112美元上调至119美元             * 特斯拉  ：杰富瑞将目标价从185美元下调至165美元             * UDR Inc   ：Piper Sandler将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","BK4566","LU1720051017.SGD","LU0011850046.USD","LU2357305700.SGD","LU0354030511.USD","BK4533","ACRE","KREF","TSLA","LU0097036916.USD","ACAD","LU1201861249.SGD","TSLL","TLRY","DCGO","LU1668664300.SGD","LU1861559042.SGD","BXMT","TWO","LU0006061336.USD","LU0354030438.USD","CG","TPG","BK4097","LU1551013425.SGD","LU0980610538.SGD","BK4175","VERA","NOW","IE00B19Z4B17.USD","VERV","BK4535","WDFC","LU2249611893.SGD","APO","OMI","LU1935042991.SGD","TRTX","LU0943347566.SGD","LU2264538146.SGD","CHK","KKR","UDR","LW","CMTG","ARI","STWD","OLMA","ABR"],"gpt_icon":0},{"id":"2424009497","title":"成分股Verve Therapeutics收跌34.95%表现最差，该公司介绍PCSK9项目的情况，宣布暂停针对高胆固醇疗法的基因编辑试验、将暂停为HEART-1临床试验招募受试对象，预计现金仍然能维持运作至2026年后期，该公司称，正调查实验室关乎安全的诸多异常现象；","url":"https://stock-news.laohu8.com/highlight/detail?id=2424009497","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424009497?lang=zh_cn&edition=full","pubTime":"2024-04-03 05:51","pubTimestamp":1712094670,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK1576","BMEA","VERV","BK4539","LENZ","BK4007","SANA","BK4585","BK1583","BK4583","BK4139","BK1141","SIGA","AMRN","03347"],"gpt_icon":0},{"id":"2424001941","title":"暴跌36%！Verve Therapeutics旗下基因编辑试验因安全问题暂停","url":"https://stock-news.laohu8.com/highlight/detail?id=2424001941","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424001941?lang=zh_cn&edition=full","pubTime":"2024-04-02 20:52","pubTimestamp":1712062345,"startTime":"0","endTime":"0","summary":"智通财经获悉，Verve Therapeutics的股价在盘前交易中暴跌，此前该公司表示，出于安全考虑，暂停了一项针对高胆固醇患者的基因编辑治疗研究的注册，这给前景光明的新医学领域带来了挫折。Verve在周二的一份声明中表示，该研究已获得英国和加拿大监管机构的临床试验许可，预计将于今年第二季度开始。这一消息对Verve来说是一个挫折，该公司旨在通过改变胆固醇升高基因来创造一种一次性治疗方法来预防心脏病发作。","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1098051.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VERV","BK4539","BK4139"],"gpt_icon":1},{"id":"2424701578","title":"BUZZ-Verve Therapeutics 暂停基因编辑疗法研究注册后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2424701578","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424701578?lang=zh_cn&edition=full","pubTime":"2024-04-02 19:51","pubTimestamp":1712058662,"startTime":"0","endTime":"0","summary":"    4月2日 - ** 基因药物公司Verve Therapeutics  股价盘前下跌33.5%至8.50美元 ** 该公司将暂停其名为VERVE-101的基因编辑疗法早期研究的 ，因为一名参与该研究的患者出现了严重的药物相关不良事件。** 该患者在服用 VERV-101 后的头四天内，体内一种致病肝酶水平升高，血小板水平异常降低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV","BK4539","BUZZ","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vervetx.com","stockEarnings":[{"period":"1week","weight":0.1051},{"period":"1month","weight":-0.3023},{"period":"3month","weight":-0.0644},{"period":"6month","weight":-0.6327},{"period":"1year","weight":-0.63},{"period":"ytd","weight":-0.6456}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verve Therapeutics, Inc.于2018年3月9日成立为特拉华州公司。他们是一家基因药物公司，开创了一种治疗心血管疾病或CVD的新方法，将治疗从慢性管理转变为单程基因编辑药物。他们认为，单疗程治疗可以为患有动脉粥样硬化性心血管疾病或ASCVD或有患动脉粥样硬化性心血管疾病风险的患者提供终生持续的显著健康益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.088813},{"month":2,"riseRate":0.666667,"avgChangeRate":0.181282},{"month":3,"riseRate":0,"avgChangeRate":-0.254413},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.262971},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049534},{"month":6,"riseRate":0.666667,"avgChangeRate":0.053142},{"month":7,"riseRate":0.75,"avgChangeRate":0.281218},{"month":8,"riseRate":0.5,"avgChangeRate":0.017273},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.13414},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.002486},{"month":11,"riseRate":0,"avgChangeRate":-0.237434},{"month":12,"riseRate":0.666667,"avgChangeRate":0.050219}],"exchange":"NASDAQ","name":"Verve Therapeutics","nameEN":"Verve Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verve Therapeutics(VERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verve Therapeutics,VERV,Verve Therapeutics股票,Verve Therapeutics股票老虎,Verve Therapeutics股票老虎国际,Verve Therapeutics行情,Verve Therapeutics股票行情,Verve Therapeutics股价,Verve Therapeutics股市,Verve Therapeutics股票价格,Verve Therapeutics股票交易,Verve Therapeutics股票购买,Verve Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verve Therapeutics(VERV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verve Therapeutics(VERV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}